SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Encouraging early-stage ESMO results for Lillys investigational ovarian-cancer drug Sofe-M plus bevacizumab are drawing attention, with traders viewing the oncology pipeline as diversification beyond obesity treatments. The findings come from a small study, so their broader significance remains uncertain.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillars upcoming quarterly report is the main focus as shares pull back sharply, with traders debating whether strong backlog and data-center power demand can withstand already-high expectations. Some expect further downside if guidance or orders disappoint, while others view the oversold pullback as a buying opportunity.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Phase 2 results for pumitamig plus docetaxel in advanced lung cancer are drawing attention, with traders weighing the reported response rate and progression-free survival against questions about how durable the benefit will be. The reaction is tempered by broader concerns about BioNTechs earlier clinical setbacks and leadership transition.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Positive prostate-cancer trial results including a reported reduction in recurrence risk and a strong tumor response rateare driving attention to J&Js oncology pipeline. Traders are weighing whether the data can support further gains or is already priced in, with some watching whether shares hold their recent advance.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

OUST is drawing attention for its sharp, volatile pullback, which traders variously blame on weakness in high-beta growth stocks or see as a buying opportunity. Bulls cite expanding lidar deploymentsincluding planned use of Rev8 sensors in John Deeres autonomous orchard machinesas support for Ousters Physical AI growth story, while skeptics question valuation, adoption and profitability.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention after a steep selloff amid concern that Auvelitys launch for Alzheimers-related agitation and prescription growth may be slower than expected. Traders disagree on whether prescription data undercounts uptake in long-term-care settings and from samples; many are looking to the Q3 report for clarity and criticizing managements silence.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is drawing attention ahead of its earnings report as traders debate whether results can halt a sharp selloff tied to weakness in crypto and AI/data-center stocks. Bearish posts fear disappointing results and exposure to CoreWeave, while some investors see the decline as overdone and are positioning for a rebound.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is drawing attention for its weakness and repeated underperformance versus Bitcoin and other crypto-linked stocks amid volatile crypto prices. Traders debate whether the slide is mainly crypto-driven or reflects company-specific concerns, with Q3 results and revenue trends also in focus.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for its prolonged sideways, choppy trading, with repeated technical posts describing consolidation and traders watching for a breakout. The community is split between dip-buying and hopes for a meme-coin rally versus frustration over weak momentum, declining-price concerns, and questions about token utility and burns.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Reports of Toshiba expanding HDD capacity for AI data centers, followed by reports that Seagate and Toshiba are bidding for TDKs HDD-head business, have fueled sharp volatility in STX and other storage shares. Traders debate whether added competition threatens the industrys supply-constrained pricing power or whether strong AI-related demand and Seagates vertical integration make the selloff overdone.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals, Inc. Announces Share Consolidation China SXT Pharmaceuticals, Inc. Announces Share ConsolidationPR NewswireTAIZHOU, China, Oct. 22, 2026 TAIZHOU, China, Oct. 22, 2026 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the "Company"), today announced that it...

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase RightPR NewswireTAIZHOU, China, Oct. 21, 2026 TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the...

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct OfferingPR NewswireTAIZHOU, China, Oct. 8, 2026TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- ChinaSXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesday's after-market session. The market value of their outstanding shares is at $1.1 million.
Neogen (NASDAQ:NEOG)read more...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Friday's after-market session. The market value of their outstanding shares is at $12.7 million.
iTonic Holdingsread more...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday's pre-market session. The company's market cap stands at $8.2 million.
China SXT Pharmaceuticals (NASDAQ:SXTC)read more...

China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why

China SXT Pharmaceuticals shares rose 25.6% after hours after announcing an ATM equity offering of up to $100 million via Univest Securities.read more...

Chinese Stocks To Keep An Eye On - April 15th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Hf Foods Group, and China SXT Pharmaceuticals are the seven Chinese stocks to watch today, according to MarketBeat's stock...

Promising Chinese Stocks To Follow Today - April 8th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, China SXT Pharmaceuticals, RBB Bancorp, and Hf Foods Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are publicly traded shares of companies that are incorporated in mainland...

Promising Chinese Stocks Worth Watching - March 30th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, China SXT Pharmaceuticals, and BGM Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies that are incorporated in or derive t...

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.

China SXT Pharmaceuticals Inc - Ordinary Shares - Class A

This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>The action will reduce outstanding shares from about 143.7 million to 958,000.</li><li>The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1 minimum bid price requirement.</li><li>SXTC shares have been under intense selling pressure since the turn of the year, declining more than 75%.</li></ul>Shares of China SXT Pharmaceuticals (SXTC) plunged nearly 30% on Friday after the company announced a 1-for-150 reverse share split, effective Feb. 3, 2026.<a href="https://stocktwits.com/symbol/SXTC">SXTC stock</a> will begin trading on a post-split basis the same day under the existing ticker symbol. The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1 minimum bid price requirement. The stock is currently trading around $0.3.The move will consolidate every 150 existing Class A shares into one new share, reducing the outstanding shares from about 143.7 million to 958,000, with fractional shares rounded up.<h2 class="st-heading-2">Selling Pressure</h2>SXTC shares have been under immense selling pressure since the turn of the year, declining more than 75%. On January 9, the stock tanked 87% after the company signed a deal with a single investor to sell about 66.7 million Class A shares, or pre-funded warrants, at $0.15 each, for gross proceeds of around $10 million. The per-share offer was at an 88% discount.Recently, China SXT Pharmaceuticals launched an AI initiative to modernize the traditional Chinese medicine raw-material supply chain. The company said it would explore AI tools for cultivation monitoring, authenticity checks, quality grading, and demand forecasting to boost traceability and planning efficiency.The company’s last reported quarterly results were for the quarter ended September 2025, when its net loss widened to $6.3 million from about $0.8 million a year earlier.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the steep intra-day decline, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/SXTC_jpg_144e91e8f3.webp" alt="SXTC.jpg">Read also: <a href="https://stocktwits.com/news-articles/markets/equity/spot-gold-silver-plunges-precious-metals-selloff/cmySYVyR4SZ">Gold Falls Below $5,000, Spot Silver Plunges 20%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

China SXT Pharmaceuticals announced a 1-for-150 reverse share split, effective Feb. 3, 2026.

China SXT Pharmaceuticals Inc

Vanguard Total Stock Market ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.041
Prev Close	$0.048
Open	$0.0421
Dividend Yield	N/A
50-Day Moving Average	$2.18
Beta	3.38
Avg. Volume	803,125.47
PE Ratio	0.00

52-Week High	$83,758.80
52-Week Low	$0.0381
Market Capitalization	$424,657.00
EPS (Annual)	-$730.39
Price to Book	0.00
Revenue Per Employee	$20,322.36

Feed

News

Sentiment

Fundamentals

Info

SXTC Fundamentals